Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
34 Cards in this Set
- Front
- Back
Demographics of AML
|
M>F, age > 65
|
|
Diagnostic finding on smear for AML
|
auer rods
|
|
Treatment for AML
|
Danorubicin + Cytarabine + Etoposide
if not in remission repeat chemo, then try BMT |
|
APL
|
-subtype of AML
-chromosomal translocation involving retinoic acid receptor -accumulation of promyelocytes |
|
Treatment of APL
|
Tretinoin + danorubicin
|
|
CML
|
-M>F, increases with age
-translocation between chrom 9 and 22= philadelphia chromosome(chrom 22) (found in 90-95% of patients) -chronic phase may progress to acute phase and blast crisis in 4 yrs if not treated |
|
CBC results for CML
|
^ WBC
^ platelets decreased rbc |
|
Blast crisis
|
acute phase of CML leukemia with blood or marrow blasts > 20%
|
|
Treatment of CML
|
Imatinib (gleevec) +/- BMT
|
|
How does Gleevec work
|
for CML
-tyrosine kinase inhibitor that targets BCR/ABL gene cells for apoptosis |
|
side effects of gleevec
|
fluid retention
nausea muscle cramps diarrhea rash |
|
Most common leukemia in childhood
|
ALL
|
|
Hematologic and bone marrow findings in ALL
|
-high or low WBC
-anemia, thrombocytopenia -smear: lymphoblasts -bone marrow: blast cells |
|
specific protein marker for ALL
|
terminal deoxynucleotidyl transferase (TdT)
|
|
Common B and T cell findings in ALL
|
-most ALL types are B cells (CD 19 and CD 10)
-T cells usually CD 2,5, and 7 |
|
treatment of ALL initially
|
prednisone+vincristine+asparaginase (in kids)
methotrexate+cytarabine for CNS prophylaxis + Gleevec if philadelphia chrom |
|
maintenance therapy for ALL
|
mercaptourine+MTX+vincristine + prednisone
for 2-3 years |
|
what differentiates myeloid leukemias from lymphoid leukemias
|
proliferation of myeloid progenitor cells
-myeloid cells make granulocytes like neutrophils, basophils and eosinophils -no lymphocyte involvement |
|
hematologic findings in AML
|
-wbc usually high
-anemia, thrombocytopenia -smear: myeloblasts -bone marrow: blast cells -auer rods is pathognomonic -CD 13 or 33 |
|
most common type of leukemia
|
CLL
|
|
hematologic findings of CLL
|
-WBC high (almost always)
-lymphocytosis -anemia, thrombocytopenia not as frequent -smear: small mature lymphocytes -bone marrow: > 30% lymphocytes |
|
lymphocyte findings in CLL
|
B cell lineage
-CD 5 and 23 |
|
Treatment for CLL
|
NO CURE
-no treatment in low risk disease: follow lymphocyte doubling time and beta 2 microglobulin -higher risk: fludarabine+cyclophosphamide+bendamustine +/- monoclonal antibodies (rituximab) |
|
hematologic findings in CML
|
-elevated WBC (always)
-anemia, thrombocytopenia -smear: immature granulocytes, blast cells <5% -low leukocyte alk phos -bone marrow: hypercellular with left shifted myelopoisis, < 5% blasts |
|
lymph node biopsy in Hodgkin lymphoma
|
Reed sternberg cell, Large multinucleated cancerous cells
|
|
Treatment of Hotchkins lymphoma
|
Chemo: doxorubicin + bleomycin + vinblastine + dacarbazine + radiation
|
|
Virus associated with Hodgkin lymphoma
|
Epstein bar virus
|
|
treatment of cdiff
|
Vanc PO 125 mg q6h x 10d. Flagyl if allergy
|
|
chemo that causes hemorrhagic cystitis
|
Cyclophosphamide
|
|
treatment of hemorrhagic cystitis
|
Mesna given with cyclophosphamide. Irrigate bladder with formalin or NAC. Prostaglandins
|
|
treatment of hemorrhagic cystitis
|
Mesna given with cyclophosphamide. Irrigate bladder with formalin or NAC. Prostaglandins
|
|
treatment of tumor lysis syndrome
|
Aggressive hydration. Sodium bicarbonate for urinary alkalinization (keep urine pH at 7 or higher). IV allopurinol. Rasburicase if uric acid still >8 after 24 hours. Follow lytes and uric acid q6h. Monitor hyperkalemia
|
|
treatment of tumor lysis syndrome
|
Aggressive hydration. Sodium bicarbonate for urinary alkalinization (keep urine pH at 7 or higher). IV allopurinol. Rasburicase if uric acid still >8 after 24 hours. Follow lytes and uric acid q6h. Monitor hyperkalemia
|
|
treatment of non Hodgkin lymphoma
|
Cyclophosphamide , doxorubicin, vincristine , prednisone. Monoclonal antibodies
|